BioMarin Pharmaceuticals
BMRN
BMRN
484 hedge funds and large institutions have $15.9B invested in BioMarin Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 202 increasing their positions, 159 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
484
Holders Change
+12
Holders Change %
+2.54%
% of All Funds
10.49%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.15%
New
54
Increased
202
Reduced
159
Closed
38
Calls
$102M
Puts
$144M
Net Calls
-$42.5M
Net Calls Change
-$61.2M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$72.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$65.6M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$49.4M |
| 4 |
ClearBridge Investments
New York
|
+$44.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$43.9M |
